Skip to content
DataLookout
Menu

ClinicalTrials.gov term: Pulmonary Disease, Chronic Obstructive

COPD clinical trials

Get alerts when COPD trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-22

What changed in the last 30 days

78 trials changed in the last 30 days: 0 stopped, 32 with notable changes, 46 with minor changes only.

  1. Minor: ISTrainingCOPD · Isoinertial Training · COPD Trial completed Universidad Manuela BeltránNot applicable NCT07605117
  2. Notable: SCOPe · Multicentric Cohort Study of Severe and Very Severe Chronic Obstructive Pulmonary Disease (COPD) in Brazil Primary completion pushed from Jul 15, 2026 to Sep 30, 2027 Hospital Israelita Albert EinsteinNot specified NCT06724315
  3. Notable: HILOT · HIgh-flow Therapy in Long-term Oxygen Therapy Primary completion pushed from Dec 2027 to Dec 2028 Skane University HospitalNot applicable NCT06247397
  4. Notable: REACT · Reducing Exposure With Air Cleaners and Technology Recruitment opened University of California, BerkeleyNot applicable NCT07914010
  5. Minor: COINCIDE · Cardineurovascular dIsease and Obstructive Airway Disease Start date pushed from Oct 15, 2026 to Nov 2026 VASCage GmbHNot specified NCT07856667
  6. Notable: Automated Versus Manual Oxygen Titration With the EMILY.AI Device · Acute Respiratory Failure Primary endpoint(s) modified Aether Tech S.L.Not applicable NCT07932847
  7. Notable: Continuation Study of Tilrekimig · Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time Recruitment opened PfizerPhase 3 NCT07839884
  8. Minor: BIPAP on Diaphragmatic Function Trial status changed: Not Yet Recruiting → Active, Not Recruiting Istanbul Demiroglu Bilim UniversityNot specified NCT07193017
  9. Notable: ALARMONY · Co-administration of GSK3862995B With GSK5784283 · Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Recruitment opened GlaxoSmithKlinePhase 2 NCT07915791
  10. Notable: Active Cycle of Breathing Techniques · Chronic Obstructive Pulmonary Disease Recruitment opened National Yang Ming Chiao Tung University HospitalNot applicable NCT07818187
  11. Minor: GSK5784283 (Felcorekibart) Compared With Placebo · Moderate to Very Severe COPD (PERSIST COPD-1) Trial sites expanded: 7 → 11 locations GlaxoSmithKlinePhase 3 NCT07780669
  12. Minor: VIGILANT · InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation Trial sites expanded: 121 → 293 locations GlaxoSmithKlinePhase 3 NCT07177339
  13. Minor: PERSEPHONE · Lunsekimig Compared With Placebo · Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype Trial sites expanded: 314 → 322 locations SanofiPhase 3 NCT07190209
  14. Minor: COLOSSUS · Lunsekimig · Chronic Obstructive Pulmonary Disease (COPD) Trial sites expanded: 8 → 16 locations SanofiPhase 3 NCT07793409
  15. Notable: Outpatient Rehabilitation Programmes for Myocardial Ischemia, Heart Failure, and COPD: Satisfaction, Participation, Test Outcomes, and Factors Associated With Positive Changes in Test Results as Well as Level of Participation Recruitment opened Nordsjaellands HospitalNot specified NCT07591792
  16. Minor: COPD at a Street Level Enrollment closed, study ongoing Hvidovre University HospitalNot applicable NCT05660460
  17. Minor: Nurse-led Motivational Interviewing Intervention Targeting Sedentary Behavior · Severe COPD: An Exploratory Pilot Study Trial status changed: Enrolling by Invitation → Completed Zealand University HospitalNot applicable NCT06882863
  18. Minor: NMES in COPD · Multimodal Assessment of Neuromuscular Electrical Stimulation (NMES) Effects on Respiratory and Peripheral Muscles in Chronic Obstructive Pulmonary Disease (COPD) Start date pushed from Oct 2026 to Nov 2026 Universitas PadjadjaranNot applicable NCT07910006
  19. Minor: Astegolimab · Chronic Obstructive Pulmonary Disease (COPD) Enrollment closed, study ongoing Hoffmann-La RochePhase 3 NCT05878769
  20. Minor: SHORE · Home Obstructive Respiratory Exacerbations Primary completion pushed from Dec 31, 2026 to Mar 31, 2027 Strados Labs, Inc.Not specified NCT06544928
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New sponsor entrants, last 90 days sponsors with their first trial in this area

First postedTrialSponsorPhase
2026-11-20 NCT07951281 Performance of Lumetry for Arterial Carbon Dioxide (paCO2) Assessment and Chronic… Lumetry Diagnostics GmbH new
2026-11-17 NCT07940608 Pilot Study of an Educational Tool for Chronic Obstructive Pulmonary Disease Prima Vard AB new
2026-11-12 NCT07932847 Automated Versus Manual Oxygen Titration With the EMILY.AI Device in Hospitalized… Aether Tech S.L. new
2026-11-12 NCT07933913 Sustainable Inhaler Prescribing in Intermediate Care Units Consorci Sanitari de l'Alt Penedès i Garraf new
2026-11-09 NCT07924462 Chronic Respiratory Disease Participant Engagement Study Richmond Research Institute new
2026-11-03 NCT07914010 Reducing Exposure With Air Cleaners and Technology University of California, Berkeley new
2026-11-02 NCT07908381 A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in… Enanta Pharmaceuticals, Inc new Phase 2/3
2026-10-21 NCT07886346 COPD Prevalence and Risk Factors Among Saudi Adults Over 18 in Taif Taif University new
2026-10-21 NCT07886502 Upper Airway Morphology and Physiology During Graded Positive Pressure and Nasal High… Klinikum Dortmund Wirbelsäulenchirurgie new
2026-10-13 NCT07871357 Urolithin A Supplementation During Pulmonary Rehabilitation in Patients With COPD Bryan A. Ross new Phase 2

Active trials by phase

Early Phase 1
4
Phase 1
19
Phase 1/2
12
Phase 2
49
Phase 2/3
8
Phase 3
37
Phase 4
31
Not charted: 670 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Get alerts when COPD trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.
Start monitoring free

Narrower conditions

Active trials